Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study - Rapoport, B; Jordan, K; Boice, J; Taylor, A; Brown, C; Hardwick, J; Carides, A; Webb, T; Schmoll, H J (Supportive Care in Cancer, 2010)